← FDA DRUG APPROVALS

FDA ANDA · ANDA074962

PENTOXIL

Sponsor: UPSHER SMITH LABS

APPLICATION
ANDA074962
TYPE
ANDA
ORIGINAL APPROVAL
1999-03-31
LATEST ACTION
2005-08-30
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PENTOXILDiscontinued
PENTOXIFYLLINE 400MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2005-08-30Labeling · Supplement 8AP
2004-10-29Labeling · Supplement 5AP
2002-12-19Manufacturing (CMC) · Supplement 3AP
2000-04-21Manufacturing (CMC) · Supplement 2AP
2000-04-21Manufacturing (CMC) · Supplement 1AP
1999-03-31OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →